AKYA Logo

Akoya Biosciences, Inc. (AKYA) 

NASDAQ
Market Cap
$127.42M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
249 of 809
Rank in Industry
14 of 49

Largest Insider Buys in Sector

AKYA Stock Price History Chart

AKYA Stock Performance

About Akoya Biosciences, Inc.

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Insider Activity of Akoya Biosciences, Inc.

Over the last 12 months, insiders at Akoya Biosciences, Inc. have bought $151,829 and sold $203,317 worth of Akoya Biosciences, Inc. stock.

On average, over the past 5 years, insiders at Akoya Biosciences, Inc. have bought $4.35M and sold $906,500 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Pla Frederic (Chief Operating Officer) — $151,829.

The last purchase of 20,000 shares for transaction amount of $92,014 was made by Pla Frederic (Chief Operating Officer) on 2023‑09‑07.

List of Insider Buy and Sell Transactions, Akoya Biosciences, Inc.

2024-06-11SaleMcKelligon BrianPresident and CEO
7,500
0.0145%
$2.08$15,630+1.83%
2024-06-06SaleMcKelligon BrianPresident and CEO
7,500
0.0146%
$2.01$15,064+5.74%
2024-03-20SaleMcKelligon BrianPresident and CEO
7,500
0.015%
$4.97$37,243-24.31%
2024-03-13SaleMcKelligon BrianPresident and CEO
7,500
0.0155%
$4.94$37,043-21.22%
2023-12-19SaleMcKelligon BrianPresident and CEO
7,500
0.0146%
$4.48$33,566-2.23%
2023-12-12SaleMcKelligon BrianPresident and CEO
7,500
0.0152%
$4.25$31,871+7.04%
2023-11-20SaleMcKelligon BrianPresident and CEO
7,500
0.0155%
$4.39$32,901+2.05%
2023-09-07PurchasePla FredericChief Operating Officer
20,000
0.0412%
$4.60$92,014-4.07%
2023-09-07PurchasePla FredericChief Operating Officer
13,000
0.0268%
$4.60$59,814-4.07%
2023-06-12PurchaseRaffin Thomas A.director
2.02M
4.8443%
$5.00$10.1M-13.79%
2023-06-12PurchaseWinkler Matthewdirector
203,388
0.4878%
$5.00$1.02M-13.79%
2023-06-12PurchaseSHEPLER ROBERT Gdirector
120,000
0.2878%
$5.00$600,000-13.79%
2023-06-12PurchaseMendel Scottdirector
20,000
0.048%
$5.00$100,000-13.79%
2023-06-12PurchaseLAI GOLDMAN MYLAdirector
20,000
0.048%
$5.00$100,000-13.79%
2023-06-12PurchaseEk John FrederickCFO
20,000
0.048%
$5.00$100,000-13.79%
2023-06-06SaleMcKelligon BrianPresident/CEO
5,000
0.0131%
$5.71$28,537-16.67%
2023-03-14SaleMcKelligon BrianPresident/CEO
5,000
0.0135%
$9.17$45,852-39.18%
2022-12-14SaleDRISCOLL JOSEPHChief Financial Officer
14,574
0.0386%
$12.46$181,519-45.72%
2022-12-13SaleSCHNETTLER THOMAS Pdirector
71,050
0.1938%
$13.03$925,782-46.46%
2022-12-13SaleNolan Garry Ph.D.director
100
0.0003%
$13.25$1,325-46.46%

Insider Historical Profitability

<0.0001%
McKelligon BrianPresident and CEO
224733
0.3109%
$2.58012
Pla FredericChief Operating Officer
13000
0.0265%
$2.5820
Raffin Thomas A.director
15937535
32.4751%
$2.5810<0.0001%
SCHNETTLER THOMAS Pdirector
2742721
5.5887%
$2.5801
Winkler Matthewdirector
984513
2.0061%
$2.5810<0.0001%
Nolan Garry Ph.D.director
555084
1.1311%
$2.58012
SHEPLER ROBERT Gdirector
369592
0.7531%
$2.5820<0.0001%
Mendel Scottdirector
28500
0.0581%
$2.5820<0.0001%
Ramachandran Niro Ph.DChief Business Officer
25073
0.0511%
$2.5820<0.0001%
LAI GOLDMAN MYLAdirector
20000
0.0408%
$2.5810<0.0001%
Ek John FrederickCFO
20000
0.0408%
$2.5810<0.0001%
DRISCOLL JOSEPHChief Financial Officer
12500
0.0255%
$2.5801

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Blue Water Life Science Advisors Llc$22.03M9.514.7M0%+$020.72
Polar Capital$7.41M3.21.58M0%+$00.04
The Vanguard Group$6.82M2.951.45M+3.28%+$216,354.40<0.0001
BlackRock$6.32M2.731.35M-1.8%-$115,810.17<0.0001
Parkman Healthcare Partners Llc$4.3M1.86917,442+35.96%+$1.14M0.53
Uniplan Investment Counsel Inc$3.28M1.42699,837+3.91%+$123,403.800.27
Silvercrest Asset Management Group Inc$2.72M1.18580,834New+$2.72M0.02
Boston Private Wealth Llc$2.42M1.04515,3170%+$00.05
Geode Capital Management$2.41M1.04514,049+3.19%+$74,457.00<0.0001
State Street$2.01M0.87428,327+19.78%+$331,751.90<0.0001
Schonfeld Group$1.76M0.76375,500+141.01%+$1.03M0.01
Peddock Capital Advisors LLC$1.13M0.49240,050-17.43%-$237,642.400.3
Northern Trust$972,682.000.42207,395-5.59%-$57,597.86<0.0001
Charles Schwab$805,629.000.35171,776-16.14%-$155,112.29<0.0001
Squarepoint Ops LLC$648,524.000.28138,278+42.66%+$193,912.79<0.01
Osterweis Capital Management$591,554.000.26126,1310%+$00.04
Morgan Stanley$299,063.000.1363,766-26.54%-$108,024.94<0.0001
Citadel Advisors LLC$284,205.000.1260,598+352.29%+$221,368.30<0.0001
BNY Mellon$272,203.000.1258,039-31.58%-$125,649.83<0.0001
Renaissance Technologies$238,000.000.150,700+6.96%+$15,491.12<0.0001
Millennium Management LLC$236,474.000.150,421-67.96%-$501,580.39<0.0001
ZWJ Investment Counsel$211,871.000.0945,1750%+$00.01
Nuveen$191,479.000.0840,8270%+$0<0.0001
Ameriprise Financial$163,446.000.0734,850-12.93%-$24,270.68<0.0001
RhumbLine Advisers$158,779.000.0733,857+2.41%+$3,742.38<0.0001
Cubist Systematic Strategies$135,919.000.0628,981-11.72%-$18,051.56<0.01
Hightower Advisors$128,000.000.0627,2000%+$0<0.0001
AllianceBernstein$127,334.000.0627,1500%+$0<0.0001
Xtx Topco Ltd$117,808.000.0525,119New+$117,808.000.01
Marshall Wace$103,259.000.0522,017New+$103,259.00<0.0001
Deutsche Bank$102,069.000.0421,7630%+$0<0.0001
UBS$100,596.000.0421,449-15.54%-$18,516.15<0.0001
Bridgeway Capital Management$96,145.000.0420,500New+$96,145.00<0.01
Dimensional Fund Advisors$86,324.000.0418,4060%+$0<0.0001
Barclays$84,000.000.0417,928-46.31%-$72,459.84<0.0001
Sherbrooke Park Advisers Llc$74,852.000.0315,960New+$74,852.000.02
Gsa Capital Partners Llp$74,000.000.0315,765New+$74,000.000.01
JPMorgan Chase$68,929.000.0314,697-0.08%-$56.28<0.0001
Jane Street Capital$63,066.000.0313,447-39.07%-$40,441.59<0.0001
Goldman Sachs$57,842.000.0312,333+22.1%+$10,468.12<0.0001
Stephens Inc.$58,489.000.0312,471-28.26%-$23,037.28<0.01
New York State Common Retirement Fund$55,000.000.0211,829+0.23%+$125.54<0.0001
American International Group$53,583.000.0211,425-0.86%-$464.31<0.0001
Regal Investment Advisors$53,560.000.0211,420+2.51%+$1,313.20<0.01
Stifel$50,318.000.0210,729+0.39%+$196.98<0.0001
The Manufacturers Life Insurance Company$49,977.000.0210,656New+$49,977.00<0.0001
Bank of America$45,483.000.029,698-55.8%-$57,418.89<0.0001
Wells Fargo$32,483.000.016,926+15.49%+$4,357.02<0.0001
NISA Investment Advisors, LLC$28,445.000.016,065+0.1%+$28.14<0.0001
Citigroup$18,127.000.013,865+13.08%+$2,096.45<0.0001